Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • V vs MRNA✓SelectedUSD · MRNAV vs MRNA performance historyLatest closeAs of-2.27%11/17
Stock and ETF performance explorer

V vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+221.7%
MRNA return
+840.0%
Excess return
-618.3%
Maximum drawdown
-36.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.3%-3.9%+1.7%-2.2%
7D-1.5%-17.6%+16.1%-1.1%
30D+3.7%-5.1%+8.9%+3.7%
3M+16.4%+220.8%-204.5%+11.7%
6M+28.4%+321.7%-293.3%+21.9%
YTD+19.8%+601.3%-581.5%+11.2%
1Y+28.9%+735.2%-706.3%+18.9%
3Y+70.8%+170.5%-99.7%+60.9%
5Y+111.1%-14.6%+125.7%+100.7%
All+221.7%+840.0%-618.3%+204.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling